Showing results (371-380 of 569) with videos related to

Sort By:
Pageof 57
The Biochemical Journal|June 8, 2001
Cloning and characterization of human liver cytosolic beta-glycosidaseM de Graaf, I C van Veen, I H van der Meulen-Muileman, et al.
Seminars in Oncology|October 1, 1994
Bioanalysis, pharmacokinetics, and pharmacodynamics of the novel anticancer drug paclitaxel (Taxol)J H Beijnen, M T Huizing, W W ten Bokkel Huinink, et al.
Cancer Research|March 1, 1992
A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavityG Los, O A Smals, M J van Vugt, et al.
Cancer Research|June 1, 1989
Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cellsH G Keizer, G J Schuurhuis, H J Broxterman, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1982
Plasma concentrations of carminomycin and carminomycinol in man, measured by high pressure liquid chromatographyJ Lankelma, P G Penders, J G McVie, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2002
BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenograftsE Boven, M Verschraagen, T M Hulscher, et al.
International Journal of Cancer|March 17, 2001
Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugateP H Houba, E Boven, I H van der Meulen-Muileman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Tumor size and origin determine the antitumor activity of cisplatin or 5-fluorouracil and its modulation by leucovorin in murine colon carcinomasJ A Van Laar, Y M Rustum, C L Van der Wilt, et al.
Lancet (London, England)|May 5, 1979
Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminomaG Stoter, D T Sleijfer, C P Vendrik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenograftsYvette van Hensbergen, Henk J Broxterman, Sareena Rana, et al.
Pageof 57